NEUROBO PHARMACEUTICALS INC (NRBO)
US64132R4048 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to NRBO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 28.22. This target is 580% above the current price.
NRBO was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NRBO.
In the previous month the buy percentage consensus was at a similar level.
NRBO was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-08 | Maxim Group | Initiate | Buy |
| 2022-12-07 | Ladenburg Thalmann | Initiate | Buy |